News
28
2018-06
23rd-24th June 2018, The Third China Summit for Retrograde Percutaneous Recanalization of Chronic Total Occlusion (RPR-CTO Summit 2018), which was hosted by Guangdong Medical Doctor Association and Guangdong Interventional Cardiology Association and organized by Guangdong People’ Hospital, was successfully convened at Dong Fang Hotel, Guangzhou China.
2018-06-28
03
2018-05
BrosMed Medical Announces Completes Successful FDA Inspection
Brosmed, Dongguan., April 28, 2018–Brosmed Medical Co. ,Ltd, a leading provider of medical device of cardiovascular and endovascular since 2012, is pleased to announce it successfully completed 4 days Quality System/Current Good Manufacturing Practice regulations for medical devices (21 CFR Part 820) inspection from FDA. This comes as a result of Brosmed medical 5 years ongoing commitment to the highest levels of quality standards.
2018-05-03
21
2018-03
The 20th South China International Congress of Cardiology
BrosMed Medical is going to exhibit Artimes™ & Artimes™ CTO semi-compliant, Apollo™ Non-compliant high pressure PTCA series, FreePath™ Sheath Introducer, and Conger™ Hydrophilic Guidewire at 20th South China International Congress of Cardiology at Guangzhou Baiyun International Convention Center, Guangzhou China, during April 5th-8th 2018.
2018-03-21
15
2018-03
The 79th China International Medical Equipment Fair (CMEF Spring 2018)
BrosMed Medical is going to exhibit Artimes™ & Artimes™ CTO semi-compliant, Apollo™ Non-compliant high pressure PTCA series, FreePath™ Sheath Introducer, and Conger Hydrophilic Guidewire at 79th China International Medical Equipment Fair (CMEF Spring 2018) during April 11th -14th 2018.
2018-03-15
11
2018-01
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA October 27th, 2017—BrosMed Medical announced CE Mark and Launched its Wedge™ Scoring PTCA Balloon for the treatment of percutaneous transluminal coronary angioplasty (PTCA) for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
2018-01-11
30
2017-08
BrosMed Medical Announces Japanese Approval and Launch of Artimes™ and Apollo™ PTCA In Japan Market
BrosMed Medical Announces Japanese Approval and Launch of Artimes™ and Apollo™ PTCA In Japan Market Aug 30th , 2017—BrosMed Medical announces Japan PMDA approval of its Artimes™ and Apollo™ PTCA balloons, and formally launches in Japan.
2017-08-30
09
2017-05
Co-exhibition in 2017 New Cardiovascular Horizons (NCVH) Annual Conference
May 10, 2017—BrosMed will co-exhibit her PTCA and PTA products family with strategic partner US Endovascular in upcoming the 2017 New Cardiovascular Horizons (NCVH) Annual Conference in New Orleans, May 31-June 02. NCVH is the international, multispecialty conference showcasing excellence in vascular medicine and intervention.
2017-05-09
02
2017-04
BrosMed Announces Strategic Agreement with Cardinal Health
BrosMed Announces Strategic Agreement with Cardinal Health March 31st, 2017 in CIT 2017 Beijing China — BrosMed announced that it has entered into a strategic distribution agreement with Cardinal Health.
2017-04-02
